10x Genomics (MEX:TXG) Research & Development: MXN4,235 Mil (TTM As of Mar. 2026)


MEX:TXG 10x Genomics Inc MEX:TXG
68 GF Score
Price MXN335.54
GF Value MXN200.14
! 8 Warning Signs
View Full Analysis

What is 10x Genomics Research & Development?

10x Genomics MEX:TXG 68 Research & Development is MXN4,235 Mil as of Mar. 2026. GuruFocus rates MEX:TXG with a GF Score™ of 68/100 and a GF Value™ of MXN200.14. The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. 10x Genomics's Research & Development for the three months ended in Mar. 2026 was MXN1,025 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was MXN4,235 Mil.

10x Genomics  (MEX:TXG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

10x Genomics Research & Development Related Terms

10x Genomics Research & Development Historical Data

* Premium members only.

The historical data trend for 10x Genomics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

10x Genomics Research & Development Chart

10x Genomics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only 4,343.88 5,179.44 4,588.68 5,520.46 4,296.74

10x Genomics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,314.34 1,152.80 1,049.18 1,007.76 1,025.11
MEX:TXG
68GF Score
10x Genomics Inc MEX:TXG
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

10x Genomics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN4,235 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of MXN4,235 Mil mean?
10x Genomics (MEX:TXG) has a Research & Development of MXN4,235 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on 10x Genomics and its competitors.
Is 10x Genomics' Research & Development too high?
10x Genomics' current Research & Development is MXN4,235 Mil. Overall, 10x Genomics has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does 10x Genomics' Research & Development compare to WAY and DOCS?
10x Genomics' Research & Development of MXN4,235 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on 10x Genomics and its competitors. 10x Genomics's current Research & Development is MXN4,235 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 10x Genomics stock overvalued right now?
10x Genomics (MEX:TXG) has a current Research & Development of MXN4,235 Mil. The stock's GF Value™ is MXN200.14, compared to a current price of MXN335.54 — trading 67.7% above its estimated fair value. The current Research & Development is MXN4,235 Mil. 10x Genomics' overall GF Score™ is 68/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For 10x Genomics (MEX:TXG), the current Research & Development is MXN4,235 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 10x Genomics (MEX:TXG) Overvalued in 2026?

Based on GuruFocus' analysis, 10x Genomics stock appears to be overvalued. The current stock price of MXN335.54 is trading 67.7% above its estimated GF Value™ of MXN200.14.

Key valuation signals for MEX:TXG:

  • Research & Development: MXN4,235 Mil
  • GF Value™: MXN200.14 vs. price of MXN335.54 (67.7% above fair value)
  • GF Score™: 68/100 with 8 warning signs

No single metric tells the full story. See the MEX:TXG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

10x Genomics Business Description

Other Exchanges TXG:USA0A88:UK1KJ:Germany
Address 6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
68GF Score

Get the complete analysis for MEX:TXG

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN335.54
Price
MXN200.14
GF Value